Obstetric Labour, Premature

11 clinical trials · Condition

Record	Firm	Date
A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor (NCT02377466)	GlaxoSmithKline	2016-02-29
Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies (NCT02292784)	GlaxoSmithKline	2015-06-01
A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour (NCT02292771)	GlaxoSmithKline	2015-03-16
Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women (NCT02377414)	GlaxoSmithKline	2015-03-02
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ) (NCT01867996)	GlaxoSmithKline	2013-06-11
This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers. (NCT01702376)	GlaxoSmithKline	2012-10-03
A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole (NCT01627587)	GlaxoSmithKline	2011-12-12
The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor (NCT00404768)	GlaxoSmithKline	2007-10-12
A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296. (NCT00549211)	GlaxoSmithKline	2007-10-01
A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects (NCT00449709)	GlaxoSmithKline	2007-03-01
Absorption, Distribution, Metabolism And Excretion Study For GSK221149A (NCT00457925)	GlaxoSmithKline	2006-10-01

Track Obstetric Labour, Premature automatically

Every clearance here is in the API, with alerts when new ones post.